Klara doubles down on growth with investment from Stage 2 Capital, a strategic VC fund focused on go-to-market

NEW YORK, March 12, 2019 /PRNewswire/ -- New York-based healthcare communication company Klara has taken its growth trajectory to the next level with recent investment from Stage 2 Capital, a fund specializing in sales, marketing, and customer success.

Last summer, Klara raised its Series A financing thanks to a round of prominent backers led by FirstMark Capital and Project A Ventures, who were joined by investors such as Flatiron Health founders Zac Weinberg and Nat Turner, Clover Health founder Vivek Garipalli, and InVision founder Clark Valberg. Only a few months later, Stage 2 Capital joins this distinguished group to help Klara's go-to-market push.

"We decided to take Stage 2 Capital on board to actively support us in our go-to-market efforts, and we're already seeing the impact," says Simon Bolz, who founded Klara together with Dr. Simon Lorenz in 2013.

Co-founded by Jay Po, former investor at Bessemer Venture Partners, and Mark Roberge, former HubSpot CRO and author of The Sales Acceleration Formula, Stage 2 Capital  supports entrepreneurs not only financially, but also by helping them achieve repeatable sales growth. Jill Rowley, formerly Chief Growth Officer at Marketo, later joined Jay and Mark as a partner.

"Mark and Jay immediately developed a deep contextual understanding of Klara, and pinpointed our growth opportunities," Lorenz explains. "They've already helped us heighten our focus to achieve more sustainable ARR growth and improve customer success, and are also working with our team to align our marketing, sales, and customer success strategies. That way, we can serve individual customer segments more effectively."

Po was quick to see Klara's potential: "We look to help companies that can demonstrate a transformative product and a clear value proposition through the validation from customer traction. Klara stood out with its strong leadership team, and its distinct chance to not only become a billion dollar business in one of the most exciting categories of software, but also to revolutionize the healthcare system and significantly improve the patient experience."

Roberge adds, "Working closely with the Klara team has allowed us to align ourselves around a future growth path. We've now developed a long-term working relationship with them, and are set up for repeatable scale and healthy growth."

About Klara

Klara is a New York-based startup with the mission to revolutionize communication for everyone involved in a patient's journey. Klara makes healthcare communication easy, integrating with a practice's website and phone system to create a central messaging platform that securely connects providers, medical professionals, and patients. This platform significantly reduces phone calls, saves medical staff hours each day, and gives patients a seamless way to navigate their healthcare. For more on Klara, visit www.klara.com or email [email protected].

About Stage 2 Capital

Stage 2 Capital is a venture capital firm that invests in early-stage B2B software companies, and sits shoulder-to-shoulder with management teams to operationalize sustainable revenue growth and sales operations. Backed by top go-to-market professionals from leading tech companies, Stage 2 Capital leverages its deep sales expertise to help entrepreneurs scale their businesses, in addition to providing capital. All inquiries about Stage2 Capital should be directed to [email protected].

Media Contact
Jenna Crane, Klara
[email protected]

SOURCE Klara

Related Links

http://www.klara.com